Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors.
Fan Z, Tian Y, Chen Z, Liu L, Zhou Q, He J, Coleman J, Dong C, Li N, Huang J, Xu C, Zhang Z, Gao S, Zhou P, Ding K, Chen L.
Fan Z, et al. Among authors: li n.
EMBO Mol Med. 2020 Jun 8;12(6):e11571. doi: 10.15252/emmm.201911571. Epub 2020 May 11.
EMBO Mol Med. 2020.
PMID: 32391629
Free PMC article.